Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Industry Today.
Press releases published on August 6, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Xellera Therapeutics. ST. PAUL, Minn., 6 August, 2025
ScaleReady Announces a G-Rex® Grant has awarded US$150K G-Rex® Grant to support Xellera Therapeutics establish a cGMP centric NK cell manufacturing platform. HONG KONG SAR, CHINA, HONG KONG, August 6, 2025 /EINPresswire.com/ -- ScaleReady, in …

ScaleReady 頒發 G-Rex® 資助予優基科技 , 聖保羅市,美國明尼蘇達州, 2025年8月6日
ScaleReady 與 Wilson Wolf Manufacturing、Bio-Techne Corporation 及 CellReady 合作,今日宣布向 優基科技 頒發 15 萬美元的 G-Rex® 資助,以支持建立高效的 cGMP 標準 G-Rex® 為核心的自然殺傷細胞(NK)生產平台 中華人民共和國香港特別行政區, HONG KONG, August 6, 2025 /EINPresswire.com/ -- ScaleReady 與 Wilson Wolf …

ScaleReady 宣布授予优基科技 G-Rex® 资助 圣保罗市,美国明尼苏达州,2025年8月6日
ScaleReady 与 Wilson Wolf Manufacturing、Bio-Techne Corporation 和 CellReady 合作,宣布向 Xellera 优基科技 颁发 15万 美元的 G-Rex® 资助,用于建立高效的 cGMP 标准 G-Rex® NK 自然杀伤细胞生产平台。 中华人民共和国香港特别行政区, HONG KONG, August 6, 2025 /EINPresswire.com/ -- ScaleReady 与 Wilson Wolf …

Groundbreaking New Research Shows Osteoarthritis of the Back and Neck Can Be Reversed
Non-Surgical Robotic Laser Spinal Decompression Shown to Reverse Degenerative Changes in the Spine OTTAWA, ONTARIO, CANADA, August 5, 2025 /EINPresswire.com/ -- Osteoarthritis of the spine, once considered a progressive and irreversible condition, now …

Beverly Hills Cosmetic Dentist Kevin Sands, DDS Featured Among Top Cosmetic Dentists Nationwide
NewsBytes has recognized Beverly Hills cosmetic dentist Kevin Sands, DDS as among the best in the country. BEVERLY HILLS, CA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- As a leading cosmetic dentist in Beverly Hills, Kevin Sands, DDS states …

BriaCell Announces Proposed Effective Date of Share Consolidation
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …